#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients
by Sibilia et al.
www.stemcellevidence.com/articles/410...
#MedSky
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients
by Sibilia et al.
www.stemcellevidence.com/articles/410...
#MedSky
BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial
by Mølhave et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial
by Mølhave et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Don't fly and freeze: impact of ex vivo time, cell density and cryopreservation on allogeneic stem cell grafts
by Novitzky-Basso et al.
www.stemcellevidence.com/articles/410...
#MedSky
Don't fly and freeze: impact of ex vivo time, cell density and cryopreservation on allogeneic stem cell grafts
by Novitzky-Basso et al.
www.stemcellevidence.com/articles/410...
#MedSky
Restrictive transfusion in acute brain injury: A #metaanalysis of randomized clinical trials
by Machado et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Restrictive transfusion in acute brain injury: A #metaanalysis of randomized clinical trials
by Machado et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
by Mohty et al.
www.stemcellevidence.com/articles/410...
#MedSky
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
by Mohty et al.
www.stemcellevidence.com/articles/410...
#MedSky
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
by Modi et al.
www.stemcellevidence.com/articles/410...
#MedSky
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
by Modi et al.
www.stemcellevidence.com/articles/410...
#MedSky
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis
by Farhadfar et al.
www.stemcellevidence.com/articles/410...
#MedSky
Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis
by Farhadfar et al.
www.stemcellevidence.com/articles/410...
#MedSky
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
Each month our clinical team picks the ten top references in the #transfusionmedicine field.
Sign up to get the alert in your inbox: www.transfusionevidencelibrary.com/alerts/latest
#MedSky
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
by Damaj et al.
www.stemcellevidence.com/articles/410...
#MedSky
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
Baseline CD4+/CD8+ TEMRA Levels and Early Response Predict Survival After Umbilical Cord-Derived Mesenchymal Stem Cells Infusion in Acute GVHD Patients (...)
by Chin et al.
www.stemcellevidence.com/articles/410...
#MedSky
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
Peripheral Blood or Bone Marrow Grafts for Mismatched Unrelated Donors with Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
by Arcuri et al.
www.stemcellevidence.com/articles/410...
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky